Neuroscience

Over 40% of Adults Struggle to Swallow Pills – BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies

VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience…

2 hours ago

Over 40% of Adults Struggle to Swallow Pills – BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies

VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience…

2 hours ago

Over 40% of Adults Struggle to Swallow Pills – BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies

VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience…

2 hours ago

Aidoc Deepens Clinical AI Leadership Through Strategic Partnerships in Neurosciences

Collaborations with Cercare Medical and Circle CVI bring advanced AI for MR Perfusion and automated ASPECTS scoring to Aidoc's aiOS™…

20 hours ago

Aidoc Deepens Clinical AI Leadership Through Strategic Partnerships in Neurosciences

Collaborations with Cercare Medical and Circle CVI bring advanced AI for MR Perfusion and automated ASPECTS scoring to Aidoc's aiOS™…

20 hours ago

Linus Health Adds Deep Clinical and Public Health Experience with Appointment of Julie Wood, MD, MPH, FAAFP, as Senior Medical Director, Clinician Engagement

BOSTON, Dec. 15, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and…

2 days ago

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company)…

2 days ago

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that…

4 days ago

Teva Releases Q4 2025 Aide Memoire

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that…

4 days ago

NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China

Publication in key market advances NewcelX's global IP strategy across Asia and supports the Company's expanding position in neurology and…

6 days ago